73
Views
32
CrossRef citations to date
0
Altmetric
Original Research

Prognostic value of the C-reactive protein to albumin ratio: a novel inflammation-based prognostic indicator in osteosarcoma

, , , , &
Pages 5255-5261 | Published online: 02 Nov 2017

References

  • MirabelloLTroisiRJSavageSAOsteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results ProgramCancer200911571531154319197972
  • LiYJDaiYLChengYSZhangWBTuCQPositron emission tomography (18)F-fluorodeoxyglucose uptake and prognosis in patients with bone and soft tissue sarcoma: a meta-analysisEur J Surg Oncol20164281103111427189833
  • MantovaniAAllavenaPSicaABalkwillFCancer-related inflammationNature2008454720343644418650914
  • DiakosCICharlesKAMcMillanDCClarkeSJCancer-related inflammation and treatment effectivenessLancet Oncol20141511e493e50325281468
  • AggarwalBBVijayalekshmiRVSungBTargeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foeClin Cancer Res200915242543019147746
  • KohCHBhoo-PathyNNgKLUtility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancerBr J Cancer2015113115015826022929
  • GuXSunSGaoXSPrognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: evidence from 3,430 patientsSci Rep201662389327025911
  • ZhuJWangHLiuCCLuYTangHThe Glasgow Prognostic Score (GPS) is a novel prognostic indicator in advanced epithelial ovarian cancer: a multicenter retrospective studyJ Cancer Res Clin Oncol2016142112339234527566683
  • LiYWangCXuMPreoperative NLR for predicting survival rate after radical resection combined with adjuvant immunotherapy with CIK and postoperative chemotherapy in gastric cancerJ Cancer Res Clin Oncol2017143586187128108815
  • IshizukaMNagataHTakagiKIwasakiYShibuyaNKubotaKClinical significance of the C-reactive protein to albumin ratio for survival after surgery for colorectal cancerAnn Surg Oncol201623390090726530445
  • LiuZJinKGuoMPrognostic value of the CRP/Alb ratio, a novel inflammation-based score in pancreatic cancerAnn Surg Oncol201724256156827650825
  • YoudenWJIndex for rating diagnostic testsCancer195031323515405679
  • CampRLDolled-FilhartMRimmDLX-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimizationClin Cancer Res200410217252725915534099
  • BalkwillFMantovaniAInflammation and cancer: back to Virchow?Lancet2001357925553954511229684
  • HeikkilaKEbrahimSLawlorDAA systematic review of the association between circulating concentrations of C reactive protein and cancerJ Epidemiol Community Health200761982483317699539
  • JablonskaEKilukMMarkiewiczWPiotrowskiLGrabowskaZJabłońskiJTNF-alpha, IL-6 and their soluble receptor serum levels and secretion by neutrophils in cancer patientsArch Immunol Ther Exp (Warsz)2001491636911266093
  • McCourtMWangJHSookhaiSRedmondHPActivated human neutrophils release hepatocyte growth factor/scatter factorEur J Surg Oncol200127439640311417987
  • McMillanDCThe systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancerCancer Treat Rev201339553454022995477
  • KantolaTKlintrupKVayrynenJPStage-dependent alterations of the serum cytokine pattern in colorectal carcinomaBr J Cancer2012107101729173623059742
  • ShamamianPSchwartzJDPocockBJActivation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesisJ Cell Physiol2001189219720611598905
  • RoxburghCSMcMillanDCCancer and systemic inflammation: treat the tumour and treat the hostBr J Cancer201411061409141224548867
  • Aggerholm-PedersenNMaretty-KongstadKKellerJBaerentzenSSafwatAThe prognostic value of serum biomarkers in localized bone sarcomaTransl Oncol20169432232827567955
  • LiXTianFWangFLiYSerum C-reactive protein and overall survival of patients with osteosarcomaTumour Biol20153675663566625986475
  • YiJHWangDLiZYHuJNiuXFLiuXLC-reactive protein as a prognostic factor for human osteosarcoma: a meta-analysis and literature reviewPLoS One201495e9463224800842
  • JiHHoughtonAMMarianiTJK-ras activation generates an inflammatory response in lung tumorsOncogene200625142105211216288213
  • SwierczakAMouchemoreKAHamiltonJAAndersonRLNeutrophils: important contributors to tumor progression and metastasisCancer Metastasis Rev201534473575126361774
  • LiMXLiuXMZhangXFPrognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysisInt J Cancer2014134102403241324122750
  • LissoniPBrivioFFumagalliLEfficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumorsInt J Biol Markers200419213514015255546
  • IshikawaSMiyashitaTInokuchiMPlatelets surrounding primary tumor cells are related to chemoresistanceOncol Rep201636278779427349611
  • OrellanaRKatoSEricesRPlatelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cellsBMC cancer20151529025886038
  • MocellinMCCamargoCQNunesEAFiatesGMRTrindadeEBSMA systematic review and meta-analysis of the n-3 polyunsaturated fatty acids effects on inflammatory markers in colorectal cancerClin Nutr201635235936925982417
  • MocellinMCPastore e Silva JdeACamargo CdeQFish oil decreases C-reactive protein/albumin ratio improving nutritional prognosis and plasma fatty acid profile in colorectal cancer patientsLipids201348987988823888317